Commentary by Zackary Berger MD PhD, PGY-2
A recent article in the New York Times publicized changes in Medicare subsidies. In the article’s own words, “Medicare will no longer pay the extra costs …
Category: Healthcare Policy
Clinical Correlations
An Update on Domestic Violence
September 6, 2007
Commentary by Sean Cavanaugh MD, Associate Editor, Clinical Correlations
Most doctors are aware that Domestic Violence, or Intimate Partner Violence (IPV), is a serious health care issue, but the statistics are still …
The Discharge Summary: A Prerequisite for Quality Care
August 24, 2007
Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
I frowned as my patient handed over some papers to me at a regularly scheduled follow-up clinic visit. For the second time in a row, …
Health Care Reform: An Overview of Recent Proposals
August 9, 2007
Commentary by Zackary Berger MD PhD, PGY-2
In the political arena, reforming health care is continually a major domestic issue. It’s no surprise that the lead 2008 democratic contenders cite the same …
$50,000: The price of a car or the price of life?
June 14, 2007
Commentary by Vlad Fridman MD, PGY-2
$50,000. This is the price of a new (and cheap) model BMW, and also a price the US government is willing to spend to prolong your medically trained (or everyone else’s …
Clinical Commentary: The Travesty of Grinding Axes with Science: Rosiglitazone and Cardiac Risk
June 12, 2007
Welcome to our first blog commentary. One of the purposes of the blog is to generate discussion about issues in health care. This “Clinical Commentary” section is an invitation to our housestaff and faculty to submit their own thoughts and …
Conflicts of Interest
March 21, 2007
The debate about the ethically questionable relationship between physicians and the pharmaceutical industry opened up again this morning on the front page of the New York Times. Although the article is heavy on interview and anecdote and a little short on …
The Vioxx Wars
February 23, 2007
Commentary By: Sandeep Mangalmurti MD, JD PGY-1
The continuing legal battles over Vioxx remain at the center of a fascinating intersection of law and medicine. Most physicians are well acquainted with the basics of the case, but …